Vitrolife Group
Ricardo Capella is an accomplished executive with extensive experience in the fields of genetics and commercial management. Currently serving as Senior Vice President of Genetics at Vitrolife Group and Chief Commercial Officer at Igenomix, Ricardo has demonstrated a strong leadership presence. In addition to advisory roles at TRÄ•KÁL Patagonia Spirit and Cerveza TYRIS, Ricardo held key positions such as Commercial Manager at Grupo Mediapro and International Sales Consultant at EXPORT BEVERAGE PARTNERS. Prior roles at C&C Group included Commercial Director for EMEA and Latin America, while Ricardo's foundational experience includes various leadership roles at Diageo. An alumnus of prestigious institutions like Esade and IESE Business School, Ricardo holds degrees in International Business and Management Development, among others.
This person is not in any offices
Vitrolife Group
The Vitrolife Group is a world-leading global provider of medical devices and genetic testing services. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarly for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced research capabilities, our aim is to deliver products and services for the entire reproductive-health journey, providing consistent performance and guaranteed quality. Currently, we are approximately 1,100 people worldwide headquartered in Gothenburg, Sweden. Our products and services are available in more than 125 countries, through our own presence in more than 25 countries and a vast network of distributors for the rest of the world. We are on a mission to be the leading global partner in reproductive health, striving for better treatment outcomes for patients.